Skip to content
Open access

Structure- and Exonuclease-Guided Engineering of Cas12o1 Enhances Genome Editing Efficiency and Deletion Outcomes

Oct 2026 · ACS Omega · Vol 11, pp. 64664 - 64672 · 0 citations · 19 references
Medicine

TL;DR

A rational framework for simultaneously enhancing the efficiency and repair outcomes of compact CRISPR nucleases is established, expanding the genome-engineering potential of Cas12o1.

Abstract

Small and efficient CRISPR nucleases hold great promise for genome engineering but often exhibit suboptimal activity and limited control over DNA repair outcomes. Here, we engineer Cas12o1 using a structure- and exonuclease-guided strategy to enhance both editing efficiency and deletion profiles in mammalian cells. Structure-guided arginine-scanning mutagenesis of 42 residues identifies a single substitution, D534R, that markedly improves editing efficiency across multiple genomic loci, outperforming combinatorial variants. In parallel, fusion of T5 exonuclease (T5 exo) profoundly remodels DNA repair outcomes, strongly enriching long-fragment deletions without compromising overall activity. Integrating the D534R mutation with T5 exo fusion increases Cas12o1 editing efficiency by 1.2–1.9-fold and yields a higher proportion of deletions exceeding 10 bp. Notably, at selected loci such as HBB, the enhanced Cas12o1-T5 exonuclease (enCas12o1-T5 exo) achieved comparable or higher editing efficiencies than canonical SpCas9 and LbCas12a. Together, these results establish a rational framework for simultaneously enhancing the efficiency and repair outcomes of compact CRISPR nucleases, expanding the genome-engineering potential of Cas12o1.

Read PDF

Similar papers

#gene editing Oct 2026

Efficient Generation of Single- and Multigene CRISPR-Cas9 Knockout in Human Cells.

An improved method for efficient generation of multi-KOs using sgRNA DNA strands and the CRISPR/Cas9 system is presented, which offers a simpler, faster, and cost-effective approach for generating multigene knockout clones, with implications for functional genomics, therapeutic development, and synthetic biology.

Yusra Manzoor, Yosra Bejaoui, D. Ramotar et al. · 0 citations
#gene editing Open access Sep 2026

Structure-guided discovery and engineering of miniature CRISPR-Cas12m for epigenome editing.

CRISPR-based epigenome editing represents a programmable strategy to precisely modulate gene expression, holding promise for therapeutic applications. However, the large size of dCas proteins substantially impedes delivery using adeno-associated virus (AAV) vectors. Here, through iterative bioinformatics analysis, stru...

Tao Yu, Meng Ji, Donglin Yu et al. · 0 citations
#gene editing Open access Sep 2026

Combinatorial CRISPR/Cas12a excises targeted loci in the mammalian genome at very low efficiency

Findings indicate that the Cas12a system does not yield locus excision at the efficiency required for sensitive negative selection assays, and showed no meaningful correlation between gRNA efficiency, orientation, GC content, or cut site geometry and the success of locus excision.

N. Anvar, Zsofia M. Szegletes, R. Steger et al. · 0 citations
#gene editing Open access Sep 2026

PS4-8. Efficient DNA-free Genome Editing in Chicken Cells by Delivering mRNA and Protein Form of cas9.

Genome editing in avian systems has largely relied on plasmid-based CRISPR systems and antibiotic selection to achieve successful editing. However, plasmid delivery can result in prolonged nuclease expression and potential unintended DNA integration. In addition, selection-based enrichment may mask the intrinsic geno...

Sydney G. Bingham, Jin Lee Kim, Kiho Lee et al. · 0 citations
#gene editing Review Sep 2026

CRISPR–Cas9 genome editing: technological advances, delivery strategies and precision engineering of primary cells for therapeutic application in genetic disorders and diabetes mellitus

Recent advances in CRISPR-Cas9–mediated genome editing are highlighted, emphasizing breakthroughs in primary cell editing and the development of translational models for genetic diseases and diabetes mellitus.

Md Nur Islam, Md. Mahmudul Islam, Han Feng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.